Semax (Research-Grade Peptide)

Synthetic ACTH(4-10) analogue — for laboratory research only

Product Overview

Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH 4–10).
Originally developed in Russia, it has been widely studied in laboratory settings for its potential
effects on the central nervous system, neuroprotection, and modulation of brain-derived neurotrophic
factor (BDNF). This material is provided as high-purity lyophilized powder for research purposes only.

Research Highlights

Neuroprotection & Ischemia Models: Preclinical studies report that Semax may
reduce neuronal damage and improve recovery in ischemia models.
PubMed
BDNF Modulation: Laboratory work indicates Semax influences expression of
brain-derived neurotrophic factor (BDNF), which is critical for synaptic plasticity and neuronal survival.
PMC
Cognitive Function Research: Experimental data suggest potential roles in learning,
memory, and adaptive responses to stress.
PubMed
Anti-inflammatory Pathways: Some studies point to modulation of inflammatory markers
in the brain following peptide administration.
PubMed

Product Details & Handling

Form: Lyophilized powder, supplied in sterile vials
Purity: ≥ 98% (Certificate of Analysis provided)
Storage: Store at –20 °C; protect from light and moisture
Handling: Use in controlled laboratory settings with appropriate PPE;
consult SDS for detailed safety instructions

Legal Disclaimer

This product is provided strictly for laboratory research use only.
It is not intended for human or veterinary consumption, therapeutic, diagnostic, or clinical application.
Customers are responsible for compliance with all applicable laws and institutional policies.
Semax is not approved by the FDA as a drug, supplement, or treatment.
Windy City Peptide does not provide medical advice or support related to human use.

Cart

You may be interested in…

Bacteriostatic Water (Bac Water)

Your cart is currently empty!

New in store